28 C
Vientiane
Sunday, June 29, 2025
spot_img
Home Blog Page 148

TalentCorp and MyDIGITAL Launch MyMahir National AI Council for Industry to Accelerate Workforce Readiness

  • Strategic Collaboration to Align AI Talent Development with Real-World Industry Needs

PETALING JAYA, Malaysia, May 23, 2025 /PRNewswire/ — Malaysia has launched a major initiative to strengthen its AI workforce development efforts through the formation of the MyMahir National AI Council for Industry (MyMahir–NAICI). Spearheaded by Talent Corporation Malaysia Berhad (TalentCorp), under the Ministry of Human Resources (KESUMA), and the National AI Office (NAIO) via MyDIGITAL Corporation (MyDIGITAL) under the Ministry of Digital, this Council provides a national platform to coordinate AI talent development, pilot adoption strategies, and drive multi-sector implementation.

From left, Mr Thomas Mathew, TalentCorp Group CEO, YB Steven Sim Chee Keong, Minister of KESUMA, YB Gobind Singh Deo, Minister of Digital and Mr Adrian Marcellus, CEO of MyDIGITAL during the exchange of Memorandum of Understanding (MoU)
From left, Mr Thomas Mathew, TalentCorp Group CEO, YB Steven Sim Chee Keong, Minister of KESUMA, YB Gobind Singh Deo, Minister of Digital and Mr Adrian Marcellus, CEO of MyDIGITAL during the exchange of Memorandum of Understanding (MoU)

Held today, the Council’s inaugural meeting marked the start of a structured, cross-agency partnership to advance Malaysia’s AI readiness. The event also included the signing of a Memorandum of Understanding (MoU) between TalentCorp and MyDIGITAL, witnessed by YB Steven Sim Chee Keong, Minister of KESUMA and YB Gobind Singh Deo, Minister of Digital.

“The question is not whether AI will replace jobs, but whether we will empower Malaysians to evolve with it,” said YB Steven Sim Chee Keong. “Through MyMahir–NAICI, we are forging a whole-of-nation mechanism, aligning skills with strategy, technology with talent, and policy with purpose. This Council is a commitment to ensure Malaysians are not just job-ready, but AI-ready.”

Reaffirming a shared commitment, YB Gobind Singh Deo added, “This is where government leadership becomes essential — building the enabling structures that connect innovation to real-world AI implementation. While NAIO focuses on creating the demand and representing deployment, TalentCorp focuses on building the talent supply and MyMahir–NAICI completing the virtuous cycle by continuously feeding back for policy improvement.”

The Council formalises a three-year collaboration focused on four strategic pillars: AI Talent Development, Industry Integration, Policy and Funding Alignment, and Stakeholder Governance. TalentCorp will serve as secretariat, with NAIO guiding alignment with the national AI roadmap.

Supporting this initiative are four key instruments:

  • The MyMahir Impact Study, which identifies affected roles, emerging jobs, and future skills;
  • The MyMahir.my platform, which enables policy-to-action implementation;
  • The G.I.A.T. Action Plan, targeting coordination across Government, Industry, Academia, and Training Providers; and
  • The AI Talent Framework, covering the full skills pipeline from digital literacy to advanced AI expertise.

According to the Impact Study, approximately 620,000 jobs, or 18% of formal sector roles in Malaysia, are expected to be significantly affected by AI over the next three to five years. At the same time, 60 emerging roles have been identified across AI, digital, green, and deep tech sectors. These findings will guide all Council-led activities, including the design of sector-based pilot programmes.

A major feature of this collaboration is the integration of the AI Readiness Index (AIRI) into the MyMahir.my platform, which allows companies to assess their AI preparedness, identify capability gaps, and take actionable steps toward transformation. Pilot use cases will also be validated through AI sandbox programmes, using real-world problem statements sourced directly from industry.

“As the strategic think tank of KESUMA, TalentCorp’s role is to link national workforce strategies with sector-driven insights and execution,” said Thomas Mathew, Group CEO of TalentCorp. “MyMahir–NAICI reflects this approach – identifying talent needs, coordinating skilling efforts, and ensuring Malaysia’s human capital policies stay agile, inclusive, and impactful.”

Adrian Marcellus, CEO of MyDIGITAL Corporation, added “NAIO’s role is to coordinate national AI policies and strategies, guide ethical innovation, and ensure that AI is deployed with purpose, trust, and impact. NAIO will play a key role in shaping national workforce foresight and helping industry navigate the AI landscape.”

The Council’s implementation and outcomes will be monitored through the newly established AI Implementation Monitoring Unit (AI-IMU). This unit will include key agencies and will track milestones, oversee delivery, and report on progress to the Ministers. It will also support the continuous improvement of sectoral workplans based on real-time feedback from Council members.

Through MyMahir–NAICI, Malaysia is strengthening its AI ecosystem by aligning innovation with talent and translating data into action. The initiative supports national priorities including the Madani Economy, NIMP 2030, and the Malaysia Digital Economy Blueprint.

For more information, visit: www.mymahir.my

MINISO Group Announces March Quarter 2025 Unaudited Financial Results

Revenue grew 18.9 % year over year

Significant sequential improvement of same-store sales(1) in MINISO mainland China for March Quarter

Gross margin reached 44.2%, up 0.8 ppt year over year

Adjusted EBITDA increased 7.5% year over year to RMB1,037.3 million

Shareholder returns reached around RMB986.9 million year to date

GUANGZHOU, China, May 23, 2025 /PRNewswire/ — MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) (“MINISO”, “MINISO Group” or the “Company”), a global value retailer offering a variety of trendy lifestyle products featuring IP design, today announced its unaudited financial results for the quarter ended March 31, 2025 (the “March Quarter”).

Financial Highlights 

  • Revenue increased 18.9 % year over year to RMB4,427.0 million (US$610.1 million).
  • Same-store sales(1) in MINISO mainland China has significantly narrowed its decline for March Quarter to mid-single digit.
  • Gross profit increased 21.1% year over year to RMB1,958.0 million (US$269.8 million).
  • Gross margin was 44.2%, compared to 43.4% in the same period last year.
  • Operating profit was RMB709.8 million (US$97.8 million), compared to RMB743.3 million in the same period last year.
  • Profit for the period was RMB416.5 million (US$57.4 million), compared to RMB586.0 million in the same period last year. Excluding other expenses and interest expenses related to issuance of equity linked securities in January 2025 (the “Equity Linked Securities”), and interest expenses related to the bank loans used for acquisition of the equity interest in Yonghui Superstores Co., Ltd*(永輝超市股份有限公司), profit for the period would have been RMB562.3 million (US$77.5 million).
  • Adjusted net profit(2) was RMB587.2 million (US$80.9 million), compared to RMB616.9 million in the same period last year.
  • Adjusted net margin(2) was 13.3%, compared to 16.6% in the same period last year.
  • Adjusted EBITDA(2) increased 7.5% year over year to RMB1,037.3 million (US$142.9 million).
  • Adjusted EBITDA margin(2) was 23.4%, compared to 25.9% in the same period of 2024.
  • Adjusted basic and diluted earnings per ADS(2) were RMB1.92 (US$0.26) and RMB1.88 (US$0.26) respectively, compared with each of RMB1.96 in the same period last year.
  • Cash Position(3) was RMB7,255.3 million (US$999.8 million) as of March 31, 2025, compared to RMB6,698.1 million as of December 31, 2024.

Operational Highlights

  • Total number of stores on group level was 7,768 as of March 31, 2025, representing a year-over-year increase of 978 net new stores.
  • Number of MINISO stores was 7,488 as of March 31, 2025, representing a year-over-year increase of 858 net new stores.
  • Number of MINISO stores in mainland China was 4,275 as of March 31, 2025, representing a year-over-year increase of 241 net new stores.
  • Number of MINISO stores in overseas markets reached 3,213 as of March 31, 2025, representing a year-over-year increase of 617 net new stores.
  • Number of TOP TOY stores was 280 as of March 31, 2025, representing a year-over-year increase of 120 net new stores. TOP TOY has also begun to expand into overseas markets since December quarter of 2024. This strategic move aligns with the Company’s plan to expand globally and strengthen its brand presence.

Notes:

(1)     “Same-store sales” refers to the daily sale on per store basis generated by those stores that opened prior to the beginning of the comparative periods and remained open as of the end of the comparative periods and closed for less than 30 days during both comparative periods.

(2)     See the sections titled “Non-IFRS Financial Measures” and “Reconciliation of Non-IFRS Financial Measures” in this press release for more information.

(3)     “Cash position” refers to the combined balance of the Company’s cash and cash equivalents, restricted cash, term deposits with original maturity over three months, and other investments recorded as current assets.

The following table provides a breakdown of the Company’s store network and its changes on a year-over-year basis. 70% of new MINISO stores in the past twelve months were located in overseas markets.

As of

March 31,

2024

March 31,

2025

YoY

Number of stores on group level

6,790

7,768

978

Number of MINISO stores

6,630

7,488

858

Mainland China

4,034

4,275

241

—Directly operated stores

29

20

(9)

—Stores operated under MINISO Retail Partner model    

3,983

4,229

246

—Stores operated under distributor model

22

26

4

Overseas

2,596

3,213

617

—Directly operated stores

281

548

267

—Stores operated under MINISO Retail Partner model

314

432

118

—Stores operated under distributor model

2,001

2,233

232

Number of TOP TOY stores

160

280

120

—Directly operated stores

17

40

23

—Stores operated under MINISO Retail Partner model

143

240

97

 

Mr. Guofu Ye, Founder, Chairman, and CEO of MINISO, commented, “We delivered a solid March Quarter to kick off 2025 and are pleased to see our revenue grow by 18.9% year over year. Our revenue growth was mainly attributable to a 9.1% revenue growth in MINISO mainland China, an acceleration from September and December quarter last year, powered by a solid recovery in same-store sales. Through our steady progress in product mix optimization and strategical store network refinement, we are confident in achieving sustainable and high-quality growth.

Revenue in MINISO overseas grew by 30.3%, with a year-over-year 3 percentage points increase in contribution to our total revenue. We are forging more holistic collaborations with our overseas partners to enhance synergies, upgrade store formats to improve operational efficiency and unlock potential in store opening space.”

“Entering into 2025, we are facing an increasingly volatile macroeconomic environment. Yet, with over ten years’ experience of globalization, unparalleled scale and diversified footprint, we will stay resilient and agile in order to deliver long-term profitable growth.” Mr. Ye continued.

Mr. Eason Zhang, CFO of MINISO, commented, “Gross margin for March Quarter reached 44.2%, which was the highest for the past March quarters ever, thanks to our solid performance from overseas markets and TOP TOY. Adjusted EBITDA grew by 7.5% year over year to RMB1,037.3 million, with an adjusted EBITDA margin of 23.4%. Our mainland franchise segment achieved a stable operating margin year over year amid a challenging environment while our investments into new businesses will open up growth opportunities over the long term.”

“MINISO Group remains steadfast in our consumer-centric strategy driving business transformation and market expansion through continuous innovation. We are committed to delivering high-quality, creatively designed products and services to our customers while generating sustainable value for shareholders. We maintained a strong cash position of RMB7,255.3 million as of March 31, 2025 and distributed cash dividends of US$101.4 million this April. Supplemented by year-to-date share repurchase of about RMB255.7 million, our returns to shareholders totaled RMB986.9 million. Moving forward, we will continue to exert effort on disciplined cost control and moderate budgeting, and balance both growth and our commitment to bringing stable and foreseeable returns to shareholders.” Mr. Zhang concluded.

Financial Results for the March Quarter

Revenue was RMB4,427.0 million (US$610.1 million), representing an increase of 18.9% year over year, primarily driven by an 16.5% year-over-year increase in average store count.

Revenue from MINISO brand increased by 16.5% to RMB4,085.8 million (US$563.0 million), driven by (i) an increase of 9.1% in mainland China, and (ii) an increase of 30.3% in overseas markets. The year-over-year increase was primarily due to an increase of 24.6% in average store count in overseas. Overseas revenue contributed to 39.0% of revenue from MINISO brand, compared to 34.8% in the same period of 2024.

Revenue from TOP TOY brand increased by 58.9% to RMB339.9 million (US$46.8 million), primarily powered by its rapid growth in average store count.

For more information on the composition and year-over-year change of revenue, please refer to the “Unaudited Additional Information” in this press release.

Cost of sales was RMB2,469.0 million (US$340.2 million), representing an increase of 17.2% year over year.

Gross profit was RMB1,958.0 million (US$269.8 million), representing an increase of 21.1% year over year.

Gross margin reached 44.2%, representing an increase of 0.8 percentage point. The year-over-year increase in gross margin was primarily due to (i) higher revenue contribution of MINISO brand from overseas markets, (ii) higher gross margin of TOP TOY due to a shift in revenue mix towards more profitable products.

Other income was RMB3.0 million (US$0.4 million), compared to RMB3.6 million in the same period of 2024.

Selling and distribution expenses were RMB1,021.2 million (US$140.7 million), increased by 46.7% year over year. Excluding share-based compensation expenses, selling and distribution expenses were RMB1,012.8 million (US$139.6 million), increased by 50.7% year over year. The year-over-year increase was mainly attributable to the Company’s investments into directly operated stores to pursue the future success of the Company’s business. As of March 31, 2025, total number of directly operated stores in overseas markets was 608, compared with 327 in the same period last year. In the March Quarter, revenue from directly operated stores has increased 85.5% year over year, while related expenses including rental and related expenses, depreciation and amortization expenses together with payroll excluding share-based compensation expenses increased 71.4%. Licensing expenses increased by 39.6%, mainly attributable to our growing IP library and enriched offerings of IP products, as a percentage of revenue stabilizing at around 2% in both comparative periods. Logistics expenses increased by 31.3% year over year.

General and administrative expenses were RMB242.1 million (US$33.4 million), increased by 26.6% year over year. Excluding share-based compensation expenses, general and administrative expenses were RMB225.6 million (US$31.1 million), increased by 22.3% year over year. The year-over-year increase was primarily due to the increase of personnel-related expenses in relation to the growth of the Company’s business.

Other net income was RMB20.8 million (US$2.9 million), compared to RMB14.8 million in the same period of 2024. The year-over-year increase was mainly due to an increase in investment income in wealth management products, and a net foreign exchange gain compared with a net foreign exchange loss in the same period last year.

Operating profit was RMB709.8 million (US$97.8 million), compared with RMB743.3 million in the same period last year.

Net finance cost was RMB49.0 million (US$6.8 million), compared to net finance income of RMB25.0 million in the same period of 2024. The year-over-year increase in finance cost was due to (i) increased interest expenses in relation to the Equity Linked Securities and the bank loans used for acquisition of the equity interest of Yonghui Superstores Co., Ltd*, both of which have been excluded in non-IFRS financial measures(1), and (ii) increased interest expenses on lease liabilities corresponding to the Company’s investment in directly operated stores.

Other expenses was RMB91.1 million (US$12.6 million), including loss from fair value change of derivatives under mark-to-market impact and issuance cost of derivatives, which is in relation to the Equity Linked Securities and has been excluded in non-IFRS financial measures(1).

Profit for the period was RMB416.5 million (US$57.4 million), compared to RMB586.0 million in the same period of 2024. Excluding other expenses and interest expenses related to issuance of the Equity Linked Securities, and interest expenses related to the bank loans used for acquisition of the equity interest in Yonghui Superstores Co., Ltd*, profit for the period would have been RMB562.3 million (US$77.5 million).

Adjusted net profit(1) was RMB587.2 million (US$80.9 million), compared to RMB616.9 million in the same period last year.

Adjusted net margin(1) was 13.3%, compared to 16.6% in the same period of 2024. 

Adjusted EBITDA(1) increased 7.5% year over year to RMB1,037.3 million (US$142.9 million).

Adjusted EBITDA margin(1) was 23.4%, compared to 25.9% in the same period of 2024.

Basic and diluted earnings per ADS were both RMB1.36 (US$0.19), compared to RMB1.88 in the same period of 2024.

Adjusted basic earnings per ADS(1) was RMB1.92 (US$0.26), compared to RMB1.96 in the same period of 2024.

Adjusted diluted earnings per ADS(1) was RMB1.88 (US$0.26), compared to RMB1.96 in the same period of 2024.

Cash position, which was the combined balance of the Company’s cash and cash equivalents, restricted cash, term deposits, and other investments recorded as current assets was RMB7,255.3 million (US$999.8 million) as of March 31, 2025, compared to RMB6,698.1 million as of December 31, 2024.

Notes:

(1)     See the sections titled “Non-IFRS Financial Measures” and “Reconciliation of Non-IFRS Financial Measures” in this press release for more information.

 

Conference Call

The Company’s management will hold an earnings conference call at 5:00 A.M. Eastern Time on Friday, May 23, 2025 (5:00 P.M. Beijing Time on the same day) to discuss the financial results. Simultaneous interpretation in English will be provided during the conference call. The conference call can be accessed by the following Zoom link or dialing the following numbers:

Access 1

Join Zoom meeting.
Zoom link: https://zoom.us/j/91867561429?pwd=O6gp0PI5MebbwUIlZ9K0Z1obVLjp0U.1
Meeting Number: 918 6756 1429
Meeting Passcode: 9896

Access 2

Listeners may access the call by dialing the following numbers with the same meeting number and passcode with access 1.

United States:

+1 689 278 1000 (or +1 719 359 4580)

Hong Kong, China:

+852 5803 3730 (or +852 5803 3731)

United Kingdom:

+44 203 481 5237 (or +44 131 460 1196)

France:

+33 1 7037 9729 (or +33 1 7037 2246)

Singapore:

+65 3158 7288 (or +65 3165 1065)

Canada:

+1 438 809 7799 (or +1 204 272 7920)

Access 3

Listeners can also access the call through the Company’s investor relations website at https://ir.miniso.com/.
The replay will be available approximately two hours after the conclusion of the live event at the Company’s investor relations website at https://ir.miniso.com/.

About MINISO Group

MINISO Group is a global value retailer offering a variety of trendy lifestyle products featuring IP design. The Company serves consumers primarily through its large network of MINISO stores, and promotes a relaxing, treasure-hunting and engaging shopping experience full of delightful surprises that appeals to all demographics. Aesthetically pleasing design, quality and affordability are at the core of every product in MINISO’s wide product portfolio, and the Company continually and frequently rolls out products with these qualities. Since the opening of its first store in China in 2013, the Company has built its flagship brand “MINISO” as a globally recognized retail brand and established a massive store network worldwide. For more information, please visit https://ir.miniso.com/.

Exchange Rate

The U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the readers. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of March 31, 2025, which was RMB7.2567 to US$1.0000. The percentages stated in this press release are calculated based on the RMB amounts.

Non-IFRS Financial Measures

In evaluating the business, MINISO considers and uses adjusted net profit, adjusted net margin, adjusted EBITDA, adjusted EBITDA margin, adjusted basic and diluted net earnings per share and adjusted basic and diluted net earnings per ADS as supplemental measures to review and assess its operating performance. The presentation of these non-IFRS financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with IFRS. MINISO defines adjusted net profit as profit for the period excluding equity-settled share-based payment expenses, gain or loss from fair value change of derivatives, issuance cost of derivatives and interest expenses related to equity linked securities and interest expenses related to the bank loans used for acquisition of the equity interest in Yonghui Superstores Co., Ltd. MINISO calculates adjusted net margin by dividing adjusted net profit by revenue for the same period. MINISO defines adjusted EBITDA as adjusted net profit plus depreciation and amortization, finance costs excluding interest expenses related to equity linked securities and interest expenses related to the bank loans used for acquisition of the equity interest in Yonghui Superstores Co., Ltd. and income tax expense. Adjusted EBITDA margin is computed by dividing adjusted EBITDA by revenue for the period. MINISO computes adjusted basic and diluted net earnings per ADS by dividing adjusted net profit attributable to the equity shareholders of the Company by the number of ADSs represented by the number of ordinary shares used in the basic and diluted earnings per share calculation on an IFRS basis. MINISO computes adjusted basic and diluted net earnings per share in the same way as it calculates adjusted basic and diluted net earnings per ADS, except that it uses the number of ordinary shares used in the basic and diluted earnings per share calculation on an IFRS basis as the denominator instead of the number of ADSs represented by these ordinary shares.

MINISO presents these non-IFRS financial measures because they are used by the management to evaluate its operating performance and formulate business plans. These non-IFRS financial measures enable the management to assess its operating results without considering the impacts of the aforementioned non-cash and other adjustment items that MINISO does not consider to be indicative of its operating performance in the future. Accordingly, MINISO believes that the use of these non-IFRS financial measures provides useful information to investors and others in understanding and evaluating its operating results in the same manner as the management and board of directors.

These non-IFRS financial measures are not defined under IFRS and are not presented in accordance with IFRS. These non-IFRS financial measures have limitations as analytical tools. One of the key limitations of using these non-IFRS financial measures is that they do not reflect all items of income and expense that affect MINISO’s operations. Further, these non-IFRS financial measures may differ from the non-IFRS information used by other companies, including peer companies, and therefore their comparability may be limited.

These non-IFRS financial measures should not be considered in isolation or construed as alternatives to profit, net profit margin, basic and diluted earnings per share and basic and diluted earnings per ADS, as applicable, or any other measures of performance or as indicators of MINISO’s operating performance. Investors are encouraged to review MINISO’s historical non-IFRS financial measures in light of the most directly comparable IFRS measures, as shown below. The non-IFRS financial measures presented here may not be comparable to similarly titled measures presented by other companies. Other companies may calculate similarly titled measures differently, limiting the usefulness of such measures when analyzing MINISO’s data comparatively. MINISO encourages you to review its financial information in its entirety and not rely on a single financial measure.

For more information on the non-IFRS financial measures, please see the table captioned “Reconciliation of Non-IFRS Financial Measures” set forth at the end of this press release.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as “may”, “will”, “expect”, “anticipate”, “aim”, “estimate”, “intend”, “plan”, “believe”, “is/are likely to”, “potential”, “continue” or other similar expressions. Among other things, the quotations from management in this announcement, as well as MINISO’s strategic and operational plans, contain forward-looking statements. MINISO may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”) and The Stock Exchange of Hong Kong Limited (the “HKEX”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about MINISO’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: MINISO’s mission, goals and strategies; future business development, financial conditions and results of operations; the expected growth of the retail market and the market of branded variety retail of lifestyle products in China and globally; expectations regarding demand for and market acceptance of MINISO’s products; expectations regarding MINISO’s relationships with consumers, suppliers, MINISO Retail Partners, local distributors, and other business partners; competition in the industry; proposed use of proceeds; and relevant government policies and regulations relating to MINISO’s business and the industry. Further information regarding these and other risks is included in MINISO’s filings with the SEC and the HKEX. All information provided in this press release and in the attachments is as of the date of this press release, and MINISO undertakes no obligation to update any forward-looking statement, except as required under applicable law.

Investor Relations Contacts:

MINISO Group Holding Limited
Email: ir@miniso.com
Phone: +86 (20) 36228788 Ext.8039

 

 

MINISO GROUP HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

(Expressed in thousands)

As at

As at

December 31, 2024

March 31, 2025

(Audited)

(Unaudited)

RMB’000

RMB’000

US$’000

ASSETS

Non-current assets

Property, plant and equipment

1,436,939

1,535,840

211,644

Right-of-use assets

4,172,083

4,319,605

595,257

Intangible assets

8,802

8,379

1,155

Goodwill

21,418

21,586

2,975

Deferred tax assets

181,948

202,417

27,894

Other investments

123,399

123,062

16,958

Trade and other receivables

341,288

288,455

39,750

Term deposits

140,183

105,592

14,551

Financial derivative assets

810,192

111,647

Interests in equity-accounted investees                               

38,567

6,307,379

869,180

6,464,627

13,722,507

1,891,011

Current assets

Other investments

100,000

150,946

20,801

Inventories

2,750,389

2,833,354

390,447

Trade and other receivables

2,207,013

2,375,133

327,302

Cash and cash equivalents

6,328,121

6,839,406

942,495

Restricted cash

1,026

1,959

270

Term deposits 

268,952

262,962

36,237

11,655,501

12,463,760

1,717,552

Total assets

18,120,128

26,186,267

3,608,563

 

 

MINISO GROUP HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (CONTINUED)

(Expressed in thousands)

As at

As at

December 31, 2024

March 31, 2025

(Audited)

(Unaudited)

RMB’000

RMB’000

US$’000

EQUITY

Share capital

94

94

13

Additional paid-in capital

4,683,577

3,954,863

544,995

Other reserves

1,329,126

1,959,579

270,037

Retained earnings

4,302,177

4,718,519

650,229

Equity attributable to equity shareholders of the Company

10,314,974

10,633,055

1,465,274

Non-controlling interests

40,548

45,411

6,258

Total equity

10,355,522

10,678,466

1,471,532

LIABILITIES

Non-current liabilities

Contract liabilities

35,145

33,381

4,600

Loans and borrowings

4,310

5,776,316

795,998

Other payables

59,842

74,844

10,314

Lease liabilities

1,903,137

2,066,649

284,792

Financial derivative liabilities

1,249,266

172,153

Deferred income

34,983

34,742

4,788

2,037,417

9,235,198

1,272,645

Current liabilities

Contract liabilities

323,292

344,665

47,496

Loans and borrowings

566,955

649,401

89,490

Trade and other payables

3,943,988

3,632,572

500,580

Lease liabilities

635,357

722,607

99,578

Deferred income

5,376

3,708

511

Current taxation

252,221

191,508

26,391

Dividend payables

728,142

100,340

5,727,189

6,272,603

864,386

Total liabilities

7,764,606

15,507,801

2,137,031

Total equity and liabilities

18,120,128

26,186,267

3,608,563

 

 

MINISO GROUP HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS

AND OTHER COMPREHENSIVE INCOME

(Expressed in thousands, except for per ordinary share and per ADS data)

Three months ended March 31,

2024

2025

(Unaudited)

(Unaudited)

RMB’000

RMB’000

US$ ‘000

Revenue

3,723,531

4,427,044

610,063

Cost of sales

(2,107,073)

(2,469,007)

(340,238)

Gross profit

1,616,458

1,958,037

269,825

Other income

3,645

3,020

416

Selling and distribution expenses

(696,027)

(1,021,186)

(140,723)

General and administrative expenses

(191,341)

(242,144)

(33,368)

Other net income

14,829

20,835

2,871

Credit loss on trade and other receivables

(667)

(8,775)

(1,209)

Impairment loss on non-current assets

(3,612)

Operating profit

743,285

709,787

97,812

Finance income

40,890

36,915

5,087

Finance costs

(15,909)

(85,945)

(11,844)

Net finance income/(cost)

24,981

(49,030)

(6,757)

Share of profit of equity-accounted investees, net of tax           

120

(2,005)

(276)

Other expenses

(91,071)

(12,550)

Profit before taxation

768,386

567,681

78,229

Income tax expense

(182,432)

(151,222)

(20,839)

Profit for the period

585,954

416,459

57,390

Attributable to:

Equity shareholders of the Company

582,472

416,342

57,374

Non-controlling interests

3,482

117

16

Earnings per share for ordinary shares

-Basic

0.47

0.34

0.05

-Diluted

0.47

0.34

0.05

Earnings per ADS

(Each ADS represents 4 ordinary shares)

-Basic

1.88

1.36

0.19

-Diluted

1.88

1.36

0.19

 

 

MINISO GROUP HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS

AND OTHER COMPREHENSIVE INCOME (CONTINUED)

(Expressed in thousands)

Three months ended March 31,

2024

2025

(Unaudited)

(Unaudited)

RMB’000

RMB’000

US$ ‘000

Profit for the period

585,954

416,459

57,390

Items that may be reclassified subsequently to profit or loss:      

Exchange differences on translation of financial statements
of foreign operations

3,855

(1,291)

(178)

Other comprehensive income/(loss) for the period

3,855

(1,291)

(178)

Total comprehensive income for the period

589,809

415,168

57,212

Attributable to:

Equity shareholders of the Company

586,166

416,306

57,369

Non-controlling interests

3,643

(1,138)

(157)

 

 

MINISO GROUP HOLDING LIMITED

RECONCILIATION OF NON-IFRS FINANCIAL MEASURES

(Expressed in thousands, except for per share, per ADS data and percentages)

Three months ended March 31,

2024

2025

(Unaudited)

(Unaudited)

RMB’000

RMB’000

US$’000

Reconciliation of profit for the period to adjusted net profit:  

Profit for the period

585,954

416,459

57,390

Add back:

Equity-settled share-based payment expenses

30,937

24,930

3,435

Loss from fair value change of derivatives

46,407

6,395

Issuance cost of derivatives

44,664

6,155

Interest expenses related to equity linked securities and
the bank loans used for acquisition of the equity interest
in Yonghui Superstores Co., Ltd.

54,745

7,544

Adjusted net profit

616,891

587,205

80,919

Adjusted net margin

16.6 %

13.3 %

13.3 %

Attributable to:

Equity shareholders of the Company

613,409

586,999

80,891

Non-controlling interests

3,482

206

28

Adjusted net earnings per share(1)

-Basic

0.49

0.48

0.07

-Diluted

0.49

0.47

0.06

Adjusted net earnings per ADS (Each ADS represents
4 ordinary shares)

-Basic

1.96

1.92

0.26

-Diluted

1.96

1.88

0.26

Reconciliation of adjusted net profit for the period to
adjusted EBITDA:

Adjusted net profit

616,891

587,205

80,919

Add back:

Depreciation and amortization

150,102

267,672

36,886

Finance costs excluding interest expenses related
to equity linked securities and the bank loans used
for acquisition of the equity interest in Yonghui
Superstores Co., Ltd.

15,909

31,200

4,300

Income tax expense

182,432

151,222

20,839

Adjusted EBITDA

965,334

1,037,299

142,944

Adjusted EBITDA margin

25.9 %

23.4 %

23.4 %

Note:

(1) Adjusted basic and diluted net earnings per share are computed by dividing adjusted net profit attributable to the equity shareholders of the Company by the number of ordinary shares used in the basic and diluted earnings per share calculation on an IFRS basis.

 

MINISO GROUP HOLDING LIMITED

UNAUDITED ADDITIONAL INFORMATION

(Expressed in thousands, except for percentages)

Three months ended March 31,

2024

2025

YoY

RMB’000

RMB’000

US$’000

Revenue

MINISO Brand

3,506,657

4,085,778

563,035

16.5 %

-Mainland China      

2,284,791

2,493,775

343,651

9.1 %

-Overseas

1,221,866

1,592,003

219,384

30.3 %

TOP TOY Brand

213,820

339,850

46,833

58.9 %

Others(1)

3,054

1,416

195

(53.6) %

3,723,531

4,427,044

610,063

18.9 %

Note:

(1) “Others” refers to revenue generated from other operating segments such as “WonderLife”, which was a secondary brand targeting on lower-tier cities in mainland China, aggregated and presented as “others”. As the MINISO brand increasingly penetrated into lower-tier cities in mainland China, “WonderLife” has become marginalized.

 

MINISO GROUP HOLDING LIMITED

UNAUDITED ADDITIONAL INFORMATION

NUMBER OF MINISO STORES IN MAINLAND CHINA

As of

March 31,

2024

March 31,

2025

YoY

By City Tiers

First-tier cities

532

569

37

Second-tier cities

1,664

1,773

109

Third- or lower-tier cities                               

1,838

1,933

95

Total

4,034

4,275

241

 

MINISO GROUP HOLDING LIMITED

UNAUDITED ADDITIONAL INFORMATION

NUMBER OF MINISO STORES IN OVERSEAS MARKETS

As of

By Regions

March 31,
2024

March 31,
2025

YoY

Asia excluding China                                     

1,402

1,663

261

North America

191

375

184

Latin America

563

646

83

Europe

237

301

64

Others

203

228

25

Total

2,596

3,213

617

*For identification purpose only

 

RightShip Seeks New Competencies to Remain Leaders in Maritime AI

SINGAPORE, May 23, 2025 /PRNewswire/ — RightShip’s mission is to enable our customers to achieve Zero Harm in the global maritime value chain – zero harm to vessels, to people, and to environment – through unique data and actionable insights. We do this by constantly strengthening our market and product relevance and augmenting our data and technology capabilities.

As the need for safety in the global supply chain increases and the development of data and technology accelerates, so does the potential and the pace of RightShip’s growth. To support our growth ambition, we are currently exploring strategic options to bring in a new minority investor who shares the same mission, purpose and values as RightShip and its current shareholders. The existing investors, BHP, Cargill and Rio Tinto, will remain as shareholders and continue to fully support RightShip through its next phase of growth. This consideration is driven by our commitment to delivering long-term value to our customers, employees, shareholders, and the global maritime industry.

Our primary goal is to partner with an investor who brings not only capital but also significant expertise in data and technology and transformational growth. We will seek a partner with the ability to provide valuable insights, resources, and track records that will support RightShip to accelerate our growth initiatives. Together, we will innovate our product offerings, supercharge our data, technology and AI capabilities and deliver delightful customer experiences – all with the intention of working to achieve zero harm in the maritime industry. To this end, RightShip has engaged Rothschild C Co as the financial advisor acting on behalf of RightShip and its shareholders.

Our decision to explore this opportunity is rooted in our dedication to maintaining the highest standards of transparency and integrity. We are early in the process and committed to conducting this process with the utmost confidentiality and discretion to prevent any market speculation or disruption. We will keep our stakeholders informed as we progress and ensure that any decisions made are in the best interests of our valued customers, the company, its employees and our future.

We appreciate the continued support and trust of our shareholders, customers, and employees as we navigate this exciting phase of our company’s journey.

About RightShip

Established in 2001, RightShip is a leading global ESG-focused digital maritime platform, providing expertise in global safety, sustainability and social responsibility practices. Founded with the mission to drive operational improvements in the global shipping industry, more than 850 customers use RightShip’s due diligence, environmental and inspections services to help them manage risk and improve overall maritime safety standards.

For Any Media Queries: 
Deepti Pathak
Head of Marketing and Communications, RightShip
Deepti.Pathak@rightship.com 

England’s NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA nephropathy

First non-immunosuppressive dual-action therapy recommended by NICE for eligible patients with IgA nephropathy, a leading cause of kidney failure 1-3

NICE’s recommendation is based on clinically meaningful results from the phase-III PROTECT trial 4

ST. GALLEN, Switzerland, May 23, 2025 /PRNewswire/ — CSL Vifor is pleased to announce that the National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending that sparsentan can be used in the NHS in England as an option to treat primary IgA nephropathy in adults with a urine protein excretion of 1.0 g/day or more, or a urine protein-to-creatinine ratio of 0.75 g/g or more.3 NICE has provided guidance to ensure that only patients responding to treatment continue.3 The decision follows authorisation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) in April 2025.5

What this means in practice is that there is enough evidence to show that sparsentan provides benefits and value for money, so it can be used routinely if it is considered the most suitable treatment option in this population.3 Sparsentan must be funded in England within 90 days of final publication of this guidance3 which is expected to be 27 June 2025.

Professor Jonathan Barratt, Professor of Renal Medicine at University Leicester, UK, welcomed the NICE decision as a major advancement in the treatment of IgA nephropathy in the UK. “IgA nephropathy is a condition with an average age at diagnosis of around 40 years.6 Due to disease progression, a patient’s kidneys may fail. Treatments, such as sparsentan, that have been developed for IgA nephropathy are urgently needed, our goal being to improve outcomes for these patients.”

IgA nephropathy is characterised by the buildup of a faulty version of immunoglobulin A (IgA), which accumulates in clusters in small blood vessels in the kidney, called glomeruli, that filter the blood. These clumps damage the glomeruli causing leakage of blood (haematuria) and protein (proteinuria) into the urine resulting in a progressive loss of kidney function. Proteinuria is a major risk factor for IgA nephropathy progression, increasing the risk of kidney failure.6-8 Despite current treatments, some patients with IgA nephropathy do not achieve adequate proteinuria reduction and remain at risk of progression.9

Although classified as rare, IgA nephropathy is the most common type of primary glomerular disease worldwide, with over 22,000 adults estimated to have the condition in England.10 Patients generally face a poor prognosis if the condition is not appropriately controlled, with approximately 30-40% of patients developing kidney failure within 10 years of diagnosis.11

Current medical treatment guidelines by KDIGO (Kidney Disease, Improving Global Outcomes) state that patients who are at high risk of progressive chronic kidney disease, despite maximal supportive care, are those with persistent urine protein excretion >1 g/day.12

Underscoring the importance of the NICE recommendation for IgA nephropathy patients and their communities, Dr. Vinicius Gomes De Lima, Head of Global Medical Affairs at CSL Vifor said: “We are very pleased that NICE recognised the value of our innovative therapy which helps to address a clear unmet medical need in patients with IgA nephropathy. We look forward to working with the National Health Service to ensure access to this important medicine as soon as possible as we continue to deliver on our promise to patients.”

CSL Vifor expects to launch sparsentan in the UK in the second half of 2025; commercial stock will be available from July 2025.

Notes to Editors

On 15th April 2025, the MHRA granted the marketing authorisation for sparsentan based on the final results of the Phase 3 PROTECT double blind study.

About CSL Vifor

CSL Vifor is a global partner of choice for pharmaceuticals and innovative, leading therapies in iron deficiency and nephrology. We specialise in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision healthcare, aiming to help patients around the world lead better, healthier lives. Headquartered in St. Gallen, Switzerland, CSL Vifor also includes the joint company Vifor Fresenius Medical Care Renal Pharma (with Fresenius Medical Care). The parent company, CSL (ASX: CSL; USOTC: CSLLY), headquartered in Melbourne, Australia, employs 32,000 people and delivers its lifesaving therapies to people in more than 100 countries. For more information about CSL Vifor visit, cslvifor.com.

About IgA nephropathy

Primary immunoglobulin A nephropathy (IgA nephropathy) is a rare, progressive type of chronic kidney disease (CKD) that is often diagnosed in adults before the age of 40 years.6 CKD is characterised by abnormalities of kidney function or structure that have been present for more than three months and can be categorised into five stages dependent on functionality of the kidney.13 Dialysis (a medical treatment used to artificially filter waste products and excess fluids from the blood when the kidneys are unable to perform this function adequately)14 or kidney transplantation is recommended for patients whose kidneys have reached an advanced stage (typically, stage 5).15  More than 60 per cent of adult patients diagnosed with IgA nephropathy are in CKD stage 3 or higher.6 Patients with this condition may experience blood in the urine (red or dark brown urine), foamy urine from protein leaking into the urine, flank pain, swelling (oedema), high blood pressure, and fatigue.16

About FILSPARI® (sparsentan)

Sparsentan was developed by Travere Therapeutics and has been granted Orphan Drug Designation for the treatment of IgA nephropathy in the UK, Europe and the U.S. Sparsentan is currently available in the U.S. and first markets in Europe. CSL Vifor has been granted exclusive commercialisation rights for sparsentan in Europe, Australia and New Zealand. Sparsentan is anticipated to be available to patients in the UK in the second half of 2025.

Sparsentan is the first and only non-immunosuppressive treatment for IgA nephropathy that has two modes of action.1 This single molecule functions as a high affinity, dual-acting antagonist of both the endothelin A receptor (ETAR) and the angiotensin II subtype 1 receptor (AT1R).4 Sparsentan inhibits activation of both ETAR and AT1R, both of which play a role in regulating processes in the kidney, such as inflammation, that lead to progression of kidney damage.4

About PROTECT  

NICE’s recommendation is based on data from the pivotal Phase 3 PROTECT study4 of sparsentan in IgA nephropathy, one of the largest interventional studies to date in IgA nephropathy and the only head-to-head trial in this rare kidney disease. It is a global, randomised, multicentre, double-blind, parallel-arm, active-controlled clinical trial evaluating the safety and efficacy of 400 mg of sparsentan, compared to 300 mg of irbesartan (an angiotensin II receptor blocker(ARB)), in 404 patients ages 18 years and up with IgA nephropathy and persistent proteinuria despite receiving at least 50% of maximum label dose and maximally tolerated angiotensin-converting enzyme (ACE) inhibitors or ARB therapy.4,17

The PROTECT study met its primary endpoint at the pre-specified interim analysis with statistical significance.4 After 36 weeks of treatment, patients receiving sparsentan (n=202) achieved a mean reduction in proteinuria from baseline of 49.8 percent, compared to a mean reduction in proteinuria from baseline of 15.1 percent for irbesartan-treated patients (n=202).4,17 Treatment emergent adverse events and serious adverse events were well-balanced between sparsentan and irbesartan, except for dizziness (30 [15%] vs 13 [6%] patients) and hypotension (26 (13%] vs eight (4%] patients).4 For more information, please refer to the Summary of Product Characteristics (SmPC).18,19

References:

  1. Trachtman H, et al. Sparsentan: the first and only non-immunosuppressive therapy for the reduction of proteinuria in IgA nephropathy. Expert Rev Clin Immunol. 2024 Jun;20(6):571-576. doi: 10.1080/1744666X.2024.2319132.
  2. Komers R, et al. Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease. Am J Physiol Regul Integr Comp Physiol. 2016 May 15;310(10):R877-84. doi: 10.1152/ajpregu.00425.2015.
  3. NICE Draft Final Guidance on sparsentan (May 2025).
  4. Rovin BH, et al. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4.
  5. Travere Therapeutics and CSL Vifor Announce Standard EU Approval of FILSPARI® (sparsentan) for IgA Nephropathy; press release (April 2025).
  6. Pitcher D, et al. Long-Term Outcomes in IgA Nephropathy. Clin J Am Soc Nephrol. 2023;18(6):727–38.av.
  7. Reich HN, et al. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol. 2007;18:3177–83.
  8. Sharma S, et al. From Proteinuria to Fibrosis: An Update on Pathophysiology and Treatment Options. Kidney Blood Press Res. 2021;46:411−20.
  9. Bagchi S, et al. Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study. Kidney Int Rep. 2021 Feb 26;6(6):1661-1668. doi: 10.1016/j.ekir.2021.02.018. PMID: 34169207; PMCID: PMC8207308.
  10. European Medicines Agency (EMA). (2020) Orphan designation for the treatment of primary IgA nephropathy https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-20-2345 (accessed May 2025).
  11. Barratt J, et al. Therapy of IgA nephropathy: time for a paradigm change. Front Med (Lausanne). 2024 Aug 15;11:1461879. doi: 10.3389/fmed.2024.1461879. PMID: 39211339; PMCID: PMC11358106.
  12. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Disease, Kidney International (2021) 100, S1-S276 https://kdigo.org/wp-content/uploads/2017/02/KDIGO-Glomerular-Diseases-Guideline-2021-English.pdf (accessed May 2025).
  13. NKF Kidney Disease Stages https://kidneycareuk.org/kidney-disease-information/stages-of-kidney-disease/stages-of-chronic-kidney-disease-ckd/ (accessed May 2025).
  14. NKF Haemodialysis https://kidneycareuk.org/kidney-disease-information/treatments/patient-info-haemodialysis-hd/ (accessed May 2025).
  15. NKF Transplants for All https://www.kidney.org/transplantationNKUK Transplantation https://www.kidneyresearchuk.org/transplantation/ (accessed May 2025).
  16. Mayo Clinic What is IgA Nephropathy? https://www.mayoclinic.org/diseases-conditions/iga-nephropathy/symptoms-causes/syc-20352268 (accessed May 2025).
  17. Heerspink HJL, et al. PROTECT Investigators. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. PMID: 37015244.
  18. Filspari EU131-SmPC_SPT_UK_200mg UK SmPC (May 2025).
  19. Filspari EU131-SmPC_SPT_UK_400mg UK SmPC (May 2025).

CSL Vifor Media Contact

Thomas Hutter
+41 79 957 96 73
media@viforpharma.com

Job no: UK-SPT-25000110  Date: 23 May 2025

Sporting Goods Industry Unites: Urgent Action Needed to Tackle Physical Inactivity Crisis Projected to Cost $300B by 2030

  • The global sporting goods industry launched the first-ever Sporting Goods Physical Activity Impact Report: Moving the World Toward an Active Future at an exclusive World Health Assembly side-event in Geneva yesterday
  • The report draws attention to the escalating global physical inactivity crisis and the urgent need for increased cross-sector collaboration
  • Initiatives undertaken by members of the World Federation of the Sporting Goods Industry (WFSGI) to address physical inactivity across the globe, are highlighted
  • Speakers at the event included Sir Gareth Southgate, Assistant Director-General World Health Organization Dr Ailan Li, WFSGI CEO Emma Zwiebler, Nike’s Dan Burrows, IOC’s Dr Jane Thornton, and Dr Andy Moose of the World Economic Forum

GENEVA, May 23, 2025 /PRNewswire/ — The sporting goods industry stepped onto the global health stage at a landmark side event at the World Health Assembly this week in Geneva, hosted by the World Federation of the Sporting Goods Industry (WFSGI).

 

 

The event welcomed WFSGI members adidas, Arena, ASICS, Decathlon, Nike, On, Puma, Speedo, Specialized and Shimano, alongside leaders from the World Health Organisation, the International Olympic Committee, Business at OECD (BIAC), the World Economic Forum, and global Ministers of Health.

Introducing the report, WFSGI CEO Emma Zwiebler issued a call to action for increased cross-sector collaboration, explaining: “This is not just a health issue — it’s an economic, social and environmental imperative. This report highlights the breadth of actions our industry is taking to help empower and inspire people to live more active lives and the power of collaboration over competition amongst our member brands.”

The report underscores the urgent need to address physical inactivity — a crisis affecting over 1.8 billion adults and 81% of adolescents worldwide. With inactivity levels projected to rise to 35% by 2030, the economic toll is expected to surpass $300 billion annually.

Key highlights in the report include:

  • The sporting goods industry’s role in improving public health through inspiring campaigns, community programs, and innovative and inclusive products.
  • Case studies from WFSGI member brands such Elite Technology, Shimano, Elite International.
  • Cross-sector partnership models to move the inactive, create safe and positive experiences and shift the story.
  • The need for urgent action and increased collaboration across the sporting goods industry along with deeper engagement with governments and public sector organizations, to address the rise of global physical inactivity.

Download the full report and learn more: wfsgi.org/impact2025.

Notes to Editors

  • Images will be available here on 23rd of May at 1000 CEST.

About WFSGI

The World Federation of the Sporting Goods Industry (WFSGI) is the global voice of the sporting goods industry. Representing brands, manufacturers, retailers, and national federations, WFSGI advocates for policies and initiatives that foster health, sustainability, and economic growth through sport and physical activity.

 

Sporting Goods Industry Unites: Urgent Action Needed to Tackle Physical Inactivity Crisis Projected to Cost $300B by 2030

  • The global sporting goods industry launched the first-ever Sporting Goods Physical Activity Impact Report: Moving the World Toward an Active Future at an exclusive World Health Assembly side-event in Geneva yesterday
  • The report draws attention to the escalating global physical inactivity crisis and the urgent need for increased cross-sector collaboration
  • Initiatives undertaken by members of the World Federation of the Sporting Goods Industry (WFSGI) to address physical inactivity across the globe, are highlighted
  • Speakers at the event included Sir Gareth Southgate, Assistant Director-General World Health Organization Dr Ailan Li, WFSGI CEO Emma Zwiebler, Nike’s Dan Burrows, IOC’s Dr Jane Thornton, and Dr Andy Moose of the World Economic Forum

GENEVA, May 23, 2025 /PRNewswire/ — The sporting goods industry stepped onto the global health stage at a landmark side event at the World Health Assembly this week in Geneva, hosted by the World Federation of the Sporting Goods Industry (WFSGI).

 

 

The event welcomed WFSGI members adidas, Arena, ASICS, Decathlon, Nike, On, Puma, Speedo, Specialized and Shimano, alongside leaders from the World Health Organisation, the International Olympic Committee, Business at OECD (BIAC), the World Economic Forum, and global Ministers of Health.

Introducing the report, WFSGI CEO Emma Zwiebler issued a call to action for increased cross-sector collaboration, explaining: “This is not just a health issue — it’s an economic, social and environmental imperative. This report highlights the breadth of actions our industry is taking to help empower and inspire people to live more active lives and the power of collaboration over competition amongst our member brands.”

The report underscores the urgent need to address physical inactivity — a crisis affecting over 1.8 billion adults and 81% of adolescents worldwide. With inactivity levels projected to rise to 35% by 2030, the economic toll is expected to surpass $300 billion annually.

Key highlights in the report include:

  • The sporting goods industry’s role in improving public health through inspiring campaigns, community programs, and innovative and inclusive products.
  • Case studies from WFSGI member brands such as Asics, Shimano and Yonex, tackling access barriers for youth, women, and underserved communities.
  • Cross-sector partnership models to move the inactive, create safe and positive experiences and shift the story.
  • The need for urgent action and increased collaboration across the sporting goods industry along with deeper engagement with governments and public sector organizations, to address the rise of global physical inactivity.

Download the full report and learn more: wfsgi.org/impact2025.

Notes to Editors

  • Images will be available here on 23rd of May at 1000 CEST.

About WFSGI

The World Federation of the Sporting Goods Industry (WFSGI) is the global voice of the sporting goods industry. Representing brands, manufacturers, retailers, and national federations, WFSGI advocates for policies and initiatives that foster health, sustainability, and economic growth through sport and physical activity.

Logo: https://laotiantimes.com/wp-content/uploads/2025/05/wfsgi_logo-1.jpg

Sporting Goods Industry Unites: Urgent Action Needed to Tackle Physical Inactivity Crisis Projected to Cost $300B by 2030

  • The global sporting goods industry launched the first-ever Sporting Goods Physical Activity Impact Report: Moving the World Toward an Active Future at an exclusive World Health Assembly side-event in Geneva yesterday
  • The report draws attention to the escalating global physical inactivity crisis and the urgent need for increased cross-sector collaboration
  • Initiatives undertaken by members of the World Federation of the Sporting Goods Industry (WFSGI) to address physical inactivity across the globe, are highlighted
  • Speakers at the event included Sir Gareth Southgate, Assistant Director-General World Health Organization Dr Ailan Li, WFSGI CEO Emma Zwiebler, Nike’s Dan Burrows, IOC’s Dr Jane Thornton, and Dr Andy Moose of the World Economic Forum

GENEVA, May 23, 2025 /PRNewswire/ — The sporting goods industry stepped onto the global health stage at a landmark side event at the World Health Assembly this week in Geneva, hosted by the World Federation of the Sporting Goods Industry (WFSGI).

 

 

The event welcomed WFSGI members adidas, Arena, ASICS, Decathlon, Nike, On, Puma, Speedo, Specialized and Shimano, alongside leaders from the World Health Organisation, the International Olympic Committee, Business at OECD (BIAC), the World Economic Forum, and global Ministers of Health.

Introducing the report, WFSGI CEO Emma Zwiebler issued a call to action for increased cross-sector collaboration, explaining: “This is not just a health issue — it’s an economic, social and environmental imperative. This report highlights the breadth of actions our industry is taking to help empower and inspire people to live more active lives and the power of collaboration over competition amongst our member brands.”

The report underscores the urgent need to address physical inactivity — a crisis affecting over 1.8 billion adults and 81% of adolescents worldwide. With inactivity levels projected to rise to 35% by 2030, the economic toll is expected to surpass $300 billion annually.

Key highlights in the report include:

  • The sporting goods industry’s role in improving public health through inspiring campaigns, community programs, and innovative and inclusive products.
  • Case studies from WFSGI member brands such as Asics, Shimano and Yonex, tackling access barriers for youth, women, and underserved communities.
  • Cross-sector partnership models to move the inactive, create safe and positive experiences and shift the story.
  • The need for urgent action and increased collaboration across the sporting goods industry along with deeper engagement with governments and public sector organizations, to address the rise of global physical inactivity.

Download the full report and learn more: wfsgi.org/impact2025.

Notes to Editors

  • Images will be available here on 23rd of May at 1000 CEST.

About WFSGI

The World Federation of the Sporting Goods Industry (WFSGI) is the global voice of the sporting goods industry. Representing brands, manufacturers, retailers, and national federations, WFSGI advocates for policies and initiatives that foster health, sustainability, and economic growth through sport and physical activity.

Logo: https://laotiantimes.com/wp-content/uploads/2025/05/wfsgi_logo-2.jpg

WSPN Launches New Website, Unveiling Enhanced Vision for Next-Generation Stablecoin Infrastructure

SINGAPORE, May 23, 2025 /PRNewswire/ — Worldwide Stablecoin Payment Network (WSPN) today announced the launch of its completely redesigned website, reflecting the company’s expanded vision and capabilities as a leader in next-generation stablecoin infrastructure. The new site highlights WSPN’s commitment to advancing global value flows through efficient, secure, and low-cost payment solutions.

The revamped website showcases WSPN’s evolution beyond traditional stablecoins, emphasizing its role in reshaping the future of payments and fueling digital globalization. With a focus on practical applications for both everyday users and institutional clients, the platform details WSPN’s comprehensive suite of services designed to bridge traditional finance and Web3 environments.

“Our new website clearly showcases WSPN’s core mission: building a stablecoin ecosystem that’s accessible, practical, and transformative for users worldwide,” said Raymond Yuan, Founder & CEO of WSPN. “As we construct the financial infrastructure of the future, this digital platform serves as our bridge to communicate value to global users.”

Key Features Highlighted on the New Website

The redesigned platform showcases several core capabilities that position WSPN at the forefront of stablecoin innovation:

  • Fast, Reliable On/Off-Ramps: Seamless connections between traditional finance and Web3, supported by hundreds of integrated partners
  • Multi-Chain Availability & Conversion: Deployment across 8+ leading blockchains with advanced cross-chain conversion capabilities
  • Developer-Friendly API & Dashboard Access: Robust tools empowering developers and businesses to build scalable fintech solutions

The website also emphasizes WSPN’s impressive operational metrics, including processing over $10 million transaction volumes daily and serving more than 500 institutional clients globally. Users can complete mint and burn operations in under 5 minutes, with 1:1 lossless swaps available 24/7.

“WSPN stablecoins are purposefully evolved for everyday impact,” added Raymond. “Whether you’re an individual seeking price stability for cross-border transfers or an institution building sophisticated DeFi applications, our platform provides the security, speed, and scalability needed in today’s digital economy.”

Visit the new WSPN website at www.wspn.io to explore the full range of stablecoin solutions and learn how WSPN is advancing worldwide value flows.

About WSPN

WSPN is a leading provider of next-generation stablecoin infrastructure, committed to building a more secure, efficient, and transparent payment solution for the global economy. Their flagship product, WUSD stablecoin, is pegged 1:1 to the U.S. Dollar and aims to optimize secure digital payments for Web3 users. WSPN’s Stablecoin 2.0 approach prioritizes user-centricity, community governance, and accessibility, paving the way for widespread stablecoin adoption.

Learn more: www.wspn.ioX | LinkedIn